Available until March 5, 2026 - Online CME Course

Mayo Clinic's Ophthalmology Grand Rounds has been repurposed as an online offering for ophthalmologists, optometrists, physicians, physician assistants, nurse practitioners and nurses who are interested in learning more about a variety of medical and surgical conditions in ophthalmology.

Available until February 1, 2026

Testosterone has a variety of health benefits. It helps maintain bone density, muscle mass, red blood cell production and sexual function. Testosterone levels in men tend to peak between age 30 to 40 then gradually decline and it’s not unusual to find low testosterone levels in men over the age of 50. It’s also known that in men with hypogonadism, testosterone supplementation can improve libido, bone density and muscle mass. Should we be checking testosterone levels in our middle-age male patients? How do we determine who should receive testosterone supplementation and finally what are the risks of supplementation? In this podcast, these are all questions I’ll be asking our guest, Dr. Nahid Punjani, a urologist at the Mayo Clinic as we discuss “Testosterone Supplementation in Men”.

Available until October 31, 2025 - Online CME Course

Pharmacogenomics (PGx) is the study of how one’s genes may affect an individual's response to medication and is an emerging field within patient care. Mayo Clinic experts have created an online certificate program on how to integrate PGx into clinical practice for pharmacists, physicians, nurse practitioners, physician assistants, nurses & students. Learners enrolled in this course will enjoy over 16 hours of engaging content, including case studies and over 50 videos that can be reviewed at their own pace, anytime. Earn a certificate of completion and CME credit in the process.

Available until April 5, 2027 - Online CNE Course

This online CNE course is created by internationally known experts in the field of tobacco dependence. It will focus on the benefit patients receive when they quit tobacco during active treatment for cancer. Patients will experience reduced toxicity from treatment, a lower likelihood of cancer recurrence, reduced risks for secondary cancers, and improved specific and overall survival. Here you will discover the many tools that are available to you to help your patients make this behavior change.

Available until January 23, 2027 - Podcast Online CME Education

Kimberly James, PharmD shares developments on respiratory syncytial virus (RSV) prevention in infants.

Available until September 1, 2024 - Podcast Online CME Education

Jonathan Leung, PharmD, BCPS, BCPP provides updates on the clozapine REMS program, reviews the therapeutic benefits of clozapine, as well as key adverse events.